library.onepin.app/citrus-bergamot Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Metabolic

Metabolic Peptide Prescription drug

Citrus Bergamot

Bergamot Polyphenols · Bergamonte

Citrus bergamot (Citrus bergamia) is a fragrant citrus fruit grown almost exclusively in Calabria, southern Italy. While the essential oil is famous for flavoring Earl Grey tea and perfumery, bergamot polyphenolic fraction (BPF) extracted from the fruit's juice has emerged as one of the most clinically validated natural agents for cholesterol and metabolic syndrome management.,BPF is uniquely rich in flavonoids (especially neoeriocitrin, neohesperidin, naringin, melitidin, and brutieridin) which have HMG-CoA reductase inhibitory activity (the same enzyme statins target) plus additional benefits on inflammation, oxidative stress, and insulin signaling. Critically, melitidin and brutieridin have a chemical structure containing a 3-hydroxy-3-methylglutaric acid moiety - a natural statin-like structure that explains the cholesterol-lowering effect.,Multiple Italian RCTs (often by the Mollace research group) have demonstrated meaningful reductions in LDL, triglycerides, and lipoprotein(a), with improvements in HDL and inflammatory markers. The standardized BPF extracts (38% bergamot polyphenolic fraction) at 500-1500mg daily are typical clinical doses. Brand names like NAOMI BergaMore and Bergamonte represent these standardized extracts.

Quick Start
Route
Oral
Start low
500-1,000mg standardized BPF
Frequency
1-2x daily with meals
Timing
Anytime

Take with meals to reduce GI effects and optimize absorption. Split dosing (AM + PM) maintains steadier blood levels for chronic lipid management. Effects develop over 4-12 weeks - retest lipids at 12 weeks.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Quick Start
Conservative start
500-1,000mg standardized BPF · Oral · 1-2x daily with meals
Lowest starting point. Hold about a week to assess tolerance before stepping up.
500-1,000mg standardized BPF
1-2x daily with meals
Standard
Lipid Optimization
500-1000 mg · Oral · Daily
human clinical trial · Mollace et al. 2011 (Fitoterapia)
500-1000 mg
Daily
01

How it works

BPF flavonoids (especially brutieridin and melitidin) contain a 3-hydroxy-3-methylglutaric acid moiety that mimics statins and inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. This is mechanistically the same target as statin medications, though with lower potency.,BPF inhibits intestinal cholesterol absorption (similar to ezetimibe-like mechanism), reducing total cholesterol load.,PCSK9 reduction: BPF reduces PCSK9 levels, leading to increased LDL receptor expression on hepatocytes and enhanced LDL clearance from circulation. This is the mechanism PCSK9 inhibitor drugs target.,Insulin signaling: BPF improves insulin receptor sensitivity and downstream PI3K/Akt signaling, reducing insulin resistance in metabolic syndrome.,Antioxidant: BPF flavonoids directly scavenge ROS and induce antioxidant enzyme expression (catalase, SOD, GSH-Px).,Anti-inflammatory: NF-kB inhibition reduces TNF-alpha, IL-6, and CRP - relevant to atherosclerosis progression.,Endothelial function: improvements in eNOS expression and NO bioavailability, supporting vasodilation.

BPF flavonoids (especially brutieridin and melitidin) contain a 3-hydroxy-3-methylglutaric acid moiety that mimics statins and inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. This is mechanistically the same target as statin medications, though with lower potency.,BPF inhibits intestinal cholesterol absorption (similar to ezetimibe-like mechanism), reducing total cholesterol load.,PCSK9 reduction: BPF reduces PCSK9 levels, leading to increased LDL receptor expression on hepatocytes and enhanced LDL clearance from circulation. This is the mechanism PCSK9 inhibitor drugs target.,Insulin signaling: BPF improves insulin receptor sensitivity and downstream PI3K/Akt signaling, reducing insulin resistance in metabolic syndrome.,Antioxidant: BPF flavonoids directly scavenge ROS and induce antioxidant enzyme expression (catalase, SOD, GSH-Px).,Anti-inflammatory: NF-kB inhibition reduces TNF-alpha, IL-6, and CRP - relevant to atherosclerosis progression.,Endothelial function: improvements in eNOS expression and NO bioavailability, supporting vasodilation.

02

What to expect

Early
Days 1–7

Weeks 1-4: Tissue effects building, no subjective change.

03

Evidence

HumanPresent
AnimalPresent
In-vitroPresent
2019Clinical application of bergamot (Citrus bergamia) for reducing high cholesterol and cardiovascular disease markers · Lamiquiz-Moneo I et al, Integrative Food, Nutrition and Metabolism ↗review
2019Effect of bergamot on lipid profile in humans: A systematic review · Nauman MC, Johnson JJ, Critical Reviews in Food Science and Nutrition ↗review
2013Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia · Gliozzi M et al, International Journal of Cardiology ↗peer reviewed
2024Citrus bergamia Extract, a Natural Approach for Cholesterol and Lipid Metabolism Management: A Randomized, Double-Blind Placebo-Controlled Clinical Trial · Cicero AFG et al, Foods ↗peer reviewed
04

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

Most cardiovascular supplementsGenerally synergistic with red yeast rice (caution - both have statin-like activity), niacin, plant sterols.
Olive Leaf ExtractMollace et al. 2019 demonstrated additive lipid-lowering when combined with BPF. Both polyphenol-rich Mediterranean traditions.
BerberineBoth reduce LDL via different mechanisms - berberine via PCSK9 and gut absorption, BPF via HMG-CoA reductase. Additive lipid lowering.
Omega-3Complementary lipid effects - omega-3 strongly reduces triglycerides, BPF reduces LDL/PCSK9. Common cardiometabolic stack.

Keep separate

Statins (synergistic but monitor)BPF potentiates statin effects via shared HMG-CoA mechanism - this allows lower statin dose with equivalent LDL reduction (Gliozzi RCT). However, watch for excessive lipid lowering or muscle complaints. Coordinate with prescriber.
Red Yeast Rice (additive statin-like effect)Both have statin-like HMG-CoA inhibition. Combined effects may be excessive - choose one.
PCSK9 InhibitorsBPF reduces PCSK9 - additive effect with PCSK9 inhibitors (alirocumab, evolocumab). Generally well-tolerated but coordinate with prescriber.
Hypoglycemic medicationsBPF improves insulin sensitivity - may potentiate hypoglycemia with diabetes medications.
05

Pharmacokinetics

Illustrative plasma concentration · 24 h
Half-life
BPF flavonoids: variable, ~2-8 hours depending on specific flavonoid.
Peak · Tmax
~2-4 hours oral with food.
Elimination
~24 hours plasma. HMG-CoA inhibition effects extend longer due to enzymatic effects.
Activity
Acute absorption: 12-24 hours per dose. Lipid-lowering effects build over 4-12 weeks of consistent dosing.

Storage. Store at room temperature (20-25C) in a cool, dry place. Protect from light. Capsules shelf-stable 2+ years.

06

Regulatory status

Classified as a dietary supplement in the US - no prescription required. Approved as functional food ingredient in EU. No FDA-approved medical indication.

Put it to work

Calculate, log & track

Open Citrus Bergamot straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Citrus Bergamot in the app →

Go deeper

The guide & community

The complete Citrus Bergamot walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community